BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7281701)

  • 1. [The prognostic significance of the immune status (DNCB-test) in patients with carcinoma of the bladder, checked by observation of the course of disease (author's transl)].
    Flamm J; Burkert S
    Wien Med Wochenschr; 1981; 131(13-14):339-43. PubMed ID: 7281701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of the DNCB test in bladder cancer. Pretreatment evaluation of immune function and 5-year follow-up of patients with urinary bladder cancer.
    Flamm J; Sagaster P; Micksche M
    Urol Int; 1984; 39(5):257-63. PubMed ID: 6506358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [DNCB test and immune competence. Analysis of patients with urologic neoplasms].
    Klippel KF; Walz HP; Kreutz G; von Moltke T
    MMW Munch Med Wochenschr; 1978 Aug; 120(31):1027-8. PubMed ID: 308155
    [No Abstract]   [Full Text] [Related]  

  • 4. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNCB and PPD skin tests and prognosis in 152 patients with breast cancer. A prospective 2-year follow-up.
    Munzarová M; Kovarík J; Hlávková J; Popelínský L; Lauerová L
    Neoplasma; 1985; 32(1):45-50. PubMed ID: 3982560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
    Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
    BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder.
    May M; Nitzke T; Helke C; Vogler H; Hoschke B
    Scand J Urol Nephrol; 2004; 38(3):231-5. PubMed ID: 15204377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo skin test in carcinoma bladder.
    Gupta NP; Rajagopal V; Malaviya AN; Singh SM
    Indian J Cancer; 1984 Nov-1985 Jan; 21(5-6):163-5. PubMed ID: 6545227
    [No Abstract]   [Full Text] [Related]  

  • 10. [Value of DNFB skin testing in patients with bladder cancer (author's transl)].
    Hudemann B; Seyfarth M
    Arch Geschwulstforsch; 1980; 50(2):173-7. PubMed ID: 7436702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the dinitrochlorobenzene (DNCB) sensitization test.
    Niwa Y; Niwa H; Kohmura J; Ou DW; Yokoyama MM
    Ann Allergy; 1982 Feb; 48(2):108-12. PubMed ID: 7199878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential evaluation of DNCB reactivity in patients with primary lung cancer. Correlation with prognosis.
    Inoue H; Ishihara T; Kobayashi K; Fukai S
    J Thorac Cardiovasc Surg; 1978 Oct; 76(4):479-82. PubMed ID: 703354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of skin testing with dinitrochlorobenzene in patients with head and neck cancer.
    Osoba D; Kersey PA; Clark RM; Rosen IB
    Can J Surg; 1980 Jan; 23(1):43-4. PubMed ID: 7363157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
    Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A correlation between the histological parameters such as stromal reaction and cell-mediated immune-structure of the regional lymph nodes, and the delayed cutaneous hypersensitive reaction toward DNCB in cervical cancer (author's transl)].
    Obata N; Kodama S; Hando T; Hirogami T; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 May; 32(5):550-8. PubMed ID: 7240843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous response to dinitrochlorobenzene in patients with genito-urinary cancers.
    Duclos H; Schwarzenberg L; Duclos SH; Hugues H; Kuss R
    Biomedicine; 1977 Jan; 27(1):43-7. PubMed ID: 856314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The DNCB skin test and its comparison with the radioimmunological determination of CEA in some types of neoplasms].
    Bianucci P; Pastorino G; De Rossi O
    Minerva Med; 1979 May; 70(25):1795-801. PubMed ID: 572515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience.
    Choong NW; Quevedo JF; Kaur JS
    Cancer; 2005 Mar; 103(6):1172-8. PubMed ID: 15700264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.